Lamotrigine Extended-Release In Elderly Patients With Epilepsy

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy. This study will be carried out using an extended-release formulation of lamotrigine (LTG-XR) that will allow once-a-day dosing.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Anticonvulsants; Lamotrigine

Criteria

Inclusion criteria:

• Confident diagnosis of epilepsy

• Currently treated with one or two antiepileptic medications

• Able to complete a seizure diary

Exclusion criteria:

• History of hypersensitivity to lamotrigine

• Progressive diseases that would interfere with the study objectives